Kristina M Smith, Yigong Bu, Hiroaki Suga  Chemistry & Biology 

Slides:



Advertisements
Similar presentations
David Berry, David M Lynn, Ram Sasisekharan, Robert Langer 
Advertisements

Volume 3, Issue 6, Pages (December 2014)
Volume 11, Issue 8, Pages (August 2004)
A Strategy for Antagonizing Quorum Sensing
Amanda M. Nelson, Kathryn L. Gilliland, Zhaoyuan Cong, Diane M
Molecular Interactions in Biofilms
Jun Zhu, John J. Mekalanos  Developmental Cell 
Colleen T. Skau, David R. Kovar  Current Biology 
Microbiology: Social Suicide for a Good Cause
Volume 15, Issue 1, Pages (January 2012)
A Strategy for Antagonizing Quorum Sensing
The UBA2 Domain Functions as an Intrinsic Stabilization Signal that Protects Rad23 from Proteasomal Degradation  Stijn Heessen, Maria G. Masucci, Nico.
Volume 23, Issue 3, Pages (March 2016)
Volume 23, Issue 14, Pages (July 2013)
Tuning chemotactic responses with synthetic multivalent ligands
Assessment of strategies to increase chondrocyte viability in cryopreserved human osteochondral allografts: evaluation of the glycosylated hydroquinone,
David Berry, David M Lynn, Ram Sasisekharan, Robert Langer 
Biofilm Inhibitors that Target Amyloid Proteins
Volume 36, Issue 5, Pages (December 2009)
Volume 19, Issue 7, Pages (July 2012)
Volume 22, Issue 10, Pages (October 2015)
Fuqing Wu, David J. Menn, Xiao Wang  Chemistry & Biology 
Dinty J. Musk, David A. Banko, Paul J. Hergenrother 
Volume 37, Issue 4, Pages (February 2010)
Volume 14, Issue 1, Pages (January 2007)
Small Molecule Fluoride Toxicity Agonists
Volume 23, Issue 3, Pages (March 2016)
Volume 18, Issue 5, Pages (January 2017)
Small Molecule Fluoride Toxicity Agonists
Rasmus D. Jahnsen, Evan F. Haney, Henrik Franzyk, Robert E.W. Hancock 
Volume 15, Issue 12, Pages (December 2008)
Hiroshi Murakami, Dimitrios Kourouklis, Hiroaki Suga 
Volume 20, Issue 7, Pages (July 2013)
Volume 21, Issue 3, Pages e7 (September 2017)
PqsE of Pseudomonas aeruginosa Acts as Pathway-Specific Thioesterase in the Biosynthesis of Alkylquinolone Signaling Molecules  Steffen Lorenz Drees,
Volume 70, Issue 6, Pages (September 2006)
Quorum-sensing activity and related virulence factor expression in clinically pathogenic isolates of Pseudomonas aeruginosa  R. Le Berre, S. Nguyen, E.
Non-steroidal Anti-inflammatory Drugs Are Caspase Inhibitors
LexA Cleavage Is Required for CTX Prophage Induction
Volume 110, Issue 3, Pages (August 2002)
Volume 21, Issue 1, Pages (January 2011)
Volume 19, Issue 9, Pages (September 2012)
Volume 16, Issue 6, Pages (June 2009)
Volume 19, Issue 8, Pages (August 2012)
Biofilm inhibition assay with engineered E. coli.
Volume 21, Issue 8, Pages (August 2014)
Volume 14, Issue 7, Pages (February 2016)
Volume 160, Issue 1, Pages (January 2015)
Volume 35, Issue 2, Pages (July 2009)
AM Campbell, JB Tok, J Zhang, Y Wang, M Stein, DG Lynn, AN Binns 
Christopher W. Carroll, Maria Enquist-Newman, David O. Morgan 
Volume 11, Issue 5, Pages (May 2004)
Volume 20, Issue 3, Pages (March 2013)
Volume 17, Issue 6, Pages (June 2010)
Volume 109, Issue 4, Pages (May 2002)
Volume 139, Issue 4, Pages (November 2009)
Volume 32, Issue 5, Pages (December 2008)
Johannes Hampl, Yueh-hsiu Chien, Mark M Davis  Immunity 
Analyzing Fission Yeast Multidrug Resistance Mechanisms to Develop a Genetically Tractable Model System for Chemical Biology  Shigehiro A. Kawashima,
Geetanjali J. Jog, Jun Igarashi, Hiroaki Suga  Chemistry & Biology 
Volume 21, Issue 10, Pages (October 2014)
Volume 16, Issue 12, Pages (December 2009)
Volume 11, Issue 3, Pages (March 2004)
Targeting Bacterial Virulence
An Inhibitor of Gram-Negative Bacterial Virulence Protein Secretion
Design, Synthesis, and Evaluation of Gluten Peptide Analogs as Selective Inhibitors of Human Tissue Transglutaminase  Felix Hausch, Tuula Halttunen, Markku.
Volume 7, Issue 4, Pages (April 2014)
Volume 12, Issue 11, Pages (November 2005)
Systematic Study of Nucleosome-Displacing Factors in Budding Yeast
Volume 18, Issue 5, Pages (January 2017)
Presentation transcript:

Induction and Inhibition of Pseudomonas aeruginosa Quorum Sensing by Synthetic Autoinducer Analogs  Kristina M Smith, Yigong Bu, Hiroaki Suga  Chemistry & Biology  Volume 10, Issue 1, Pages 81-89 (January 2003) DOI: 10.1016/S1074-5521(03)00002-4

Figure 1 Chemical Structures of Autoinducers and Analogs AI1, 3-oxo-C12HSL; AI2, C4 HSL; 1, 3-oxo-C12-(2-aminocyclopentanone); 2, 3-oxo-C12-(2-aminocyclopentanol); 3, 3-oxo-C12-(2-aminocyclohexanone); 4, 3-oxo-C12-(2-aminocyclohexanol); 5, C4-(2-aminocyclopentanone); 6, C4-(2-aminocyclopentanol); 7, C4-(2-aminocyclohexanone); 8, C4-(2-aminocyclohexanol). Chemistry & Biology 2003 10, 81-89DOI: (10.1016/S1074-5521(03)00002-4)

Figure 2 Reporter Gene Induction by Autoinducers and Their Analogs (A) Molecular Imager scan of 96-well plate containing PAO-JP2 (plasI-LVAgfp) in the presence of 1, 100, and 400 μM of the designated 3-oxo-C12 compound. (B) Quantification of results of 3-oxo-C13 compounds. Cont, negative control of untreated cell (not shown in [A]). Average fluorescence of four replicate wells was corrected for cell density by dividing by OD600 of cell culture. The standard deviation was derived from three independent experiments shown in (A). (C) Molecular Imager scan of 96-well plated containing PAO-JP2 (prhlI-LVAgfp) in the presence of 1 μM AI1 and 10, 100, and 400 μM designated C4 compound. (D) Quantification of results of C4 compounds. Data analysis was the same as (B). Chemistry & Biology 2003 10, 81-89DOI: (10.1016/S1074-5521(03)00002-4)

Figure 3 Antagonist Assays (A) GFP expression by PAO-JP2 (plasI-LVAgfp) in the presence of 1 μM AI1 alone (control, black bar) or 1 μM AI1 plus 2 or 3. (B) GFP expression by PAO-JP2 (prhlI-LVAgfp) in the presence of 1 μM AI1 and 10 μM AI2 (control, black bar) or 1 μM AI1 and 10 μM AI2 plus 2 or 3. Chemistry & Biology 2003 10, 81-89DOI: (10.1016/S1074-5521(03)00002-4)

Figure 4 Virulence Factor Assays (A) Pyocyanin expression by PAO-JP2. −, negative control; +, positive control, 25 μM each of AI1 and AI2; 2, 25 μM each of AI1 and AI2 in the presence of 100 μM 2; 3, 25 μM each of AI1 and AI2 in the presence of 100 μM 3. (B) Quantification of pyocyanin expression by PAO-JP2 in the presence of various concentrations of 2 or 3. −, negative control containing no AIs (black bar); +, positive control containing 25 μM each of AI1 and AI2 (purple bar); 2, 25 μM each of AI1 and AI2 in the presence of 2; 3, 25 μM each of AI1 and AI2 in the presence of 3. (C) Quantification of pyocyanin expression of wild-type strain PAO1. The conditions are the same as (B), except for control (purple bar) where no AIs were added. (D) Elastase B activity produced by PAO-JP2 in the absence (negative control, black bar) or presence of 5 μM AI1 and 10 μM AI2 (positive control, purple bar) or 5 μM AI1 and 10 μM AI2 plus 2 or 3. (E) Elastase B activity produced by PAO1 control (purple bar) or in the presence of 2 or 3. Chemistry & Biology 2003 10, 81-89DOI: (10.1016/S1074-5521(03)00002-4)

Figure 5 Static Biofilm Assay (A) PAO-JP2 (pTdK-GFP) biofilm development in the presence of designated compounds. (B) PAO-1 (pTdK-GFP) biofilm development in the absence (negative control) or presence of 50 μM 3. Chemistry & Biology 2003 10, 81-89DOI: (10.1016/S1074-5521(03)00002-4)